These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3112014)

  • 21. Effect of T-cell depletion on the growth of BCG in the mouse footpad.
    Collins FM; Auclair L; Montalbine V
    Int Arch Allergy Appl Immunol; 1975; 48(5):680-90. PubMed ID: 805768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
    Flynn JL; Goldstein MM; Triebold KJ; Koller B; Bloom BR
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12013-7. PubMed ID: 1465432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural resistance to Salmonella typhimurium in different inbred mouse strains.
    Hormaeche CE
    Immunology; 1979 Jun; 37(2):311-8. PubMed ID: 381178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.
    Castillo-Rodal AI; Castañón-Arreola M; Hernández-Pando R; Calva JJ; Sada-Díaz E; López-Vidal Y
    Infect Immun; 2006 Mar; 74(3):1718-24. PubMed ID: 16495544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria.
    Gheorghiu M; Mouton D; Lecoeur H; Lagranderie M; Mevel JC; Biozzi G
    Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of an aerogenic BCG vaccine in T-cell-depleted and normal mice.
    Morrison NE; Collins FM
    Infect Immun; 1975 May; 11(5):1110-21. PubMed ID: 123519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG.
    Forget A; Skamene E; Gros P; Miailhe AC; Turcotte R
    Infect Immun; 1981 Apr; 32(1):42-7. PubMed ID: 7012036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
    Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
    Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell immune responses in Mycobacterium avium-infected mice.
    Hubbard RD; Flory CM; Collins FM
    Infect Immun; 1992 Jan; 60(1):150-3. PubMed ID: 1729179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis.
    Dannenberg AM
    Immunobiology; 1994 Oct; 191(4-5):461-73. PubMed ID: 7713560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ipr1 modified BCG as a novel vaccine induces stronger immunity than BCG against tuberculosis infection in mice.
    Wang Y; Yang C; He Y; Zhan X; Xu L
    Mol Med Rep; 2016 Aug; 14(2):1756-64. PubMed ID: 27356552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG).
    Stach JL; Gros P; Forget A; Skamene E
    J Immunol; 1984 Feb; 132(2):888-92. PubMed ID: 6361135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
    Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
    Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequencies of IFN gamma- and IL-4-producing cells during Mycobacterium bovis BCG infection in two genetically susceptible mouse strains: role of alpha/beta T cells and NK1.1 cells.
    Teixeira HC; Munk ME; Kaufmann SH
    Immunol Lett; 1995 May; 46(1-2):15-9. PubMed ID: 7590911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium.
    Ramarathinam L; Niesel DW; Klimpel GR
    J Immunol; 1993 May; 150(9):3965-72. PubMed ID: 8473743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.